Add-on Combination Therapy with Metformin and Rosiglitazone A total of 278 patients with type 2 diabetes participated in a 54-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of JANUVIA in combination with metformin and rosiglitazone
and (4) activated protein kinase C-mediated cell-signaling cascade, eventually leading to an increase in liver cell apoptosis (2)
For example, some documented congenital nevi have been entirely junctional (279), while the likelihood of deep dermal involvement appears to increase with the size of the lesion (282) and is actually uncommon in lesions smaller than 3 cm (277)
S.StuhlerJ
Melariri P, Campbell W, Etusim P, Smith P
Much of this evidence comes from preclinical models, so human conclusions remain limited